Co-Diagnostics, Inc.
CODXNasdaqCIK 1692415HealthcareFiscal year ends Dec 31
Reports and events: 138 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1516:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-047242 |
| 2026-10-1506:10 ET | 8-K/A | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-047089 |
| 2026-10-1306:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-046676 |
| 2026-10-0519:38 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-045652 |
| 2026-09-2516:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-044346 |
| 2026-09-1610:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042854 |
| 2026-09-1608:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042844 |
| 2026-09-1516:05 ET | 8-K | 8.01 Other events | 0001493152-26-042744 |
| 2026-09-0416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-041560 |
| 2026-09-0409:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-041468 |
| 2026-08-1316:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037762 |
| 2026-08-1316:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037739 |
| 2026-07-3108:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-035553 |
| 2026-07-2717:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-034837 |
| 2026-07-2109:00 ET | DEF 14A | Proxy statementPeriod 2026-07-21 | 0001493152-26-034021 |
| 2026-05-2108:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024738 |
| 2026-05-1416:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023085 |
| 2026-05-1416:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023059 |
| 2026-03-3116:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-014158 |
| 2026-03-3116:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-014129 |
| 2026-03-1009:25 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001493152-26-009478 |
| 2026-01-1312:23 ET | 8-K | 3.01 Delisting notice | 0001493152-26-001971 |
| 2025-12-3009:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-029513 |
| 2025-12-0516:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-026385 |
| 2025-11-1316:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022300 |
| 2025-11-1316:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022283 |
| 2025-11-1017:15 ET | DEF 14A | Proxy statementPeriod 2025-11-10 | 0001493152-25-021564 |
| 2025-10-2917:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-020100 |
| 2025-10-2009:42 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018591 |
| 2025-09-3009:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-016211 |
| 2025-09-1808:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013981 |
| 2025-08-1416:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024029 |
| 2025-08-1416:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023968 |
| 2025-07-1116:15 ET | 8-K | 8.01 Other events | 0001641172-25-018753 |
| 2025-05-2916:30 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-012871 |
| 2025-05-0816:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009257 |
| 2025-05-0816:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-009249 |
| 2025-04-2807:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-006324 |
| 2025-04-1416:30 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001641172-25-004580 |
| 2025-03-2716:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000932 |
| 2025-03-2716:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000922 |
| 2025-02-2117:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-007919 |
| 2025-01-1016:15 ET | 8-K | 3.01 Delisting notice | 0001493152-25-001705 |
| 2024-11-0816:15 ET | 8-K/A | 5.07 Shareholder vote results | 0001493152-24-044279 |
| 2024-11-0716:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044008 |
| 2024-11-0716:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044001 |
| 2024-08-3016:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-034599 |
| 2024-08-0816:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030758 |
| 2024-08-0816:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-030746 |
| 2024-07-1616:15 ET | DEF 14A | Proxy statementPeriod 2024-07-16 | 0001493152-24-028019 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:01 ET. Listed shows no prices and gives no investment advice.